All In Biotech

Investigational drug · Phase 2

gavo-cel

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura.

Phase 2

Last checked: Nov 19, 2026Latest source record: Aug 27, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

1

Any phase or sponsor naming "gavo-cel"

First trial start

2019

Apr 15, 2019

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "gavo-cel", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Mesothelioma
  • Mesothelioma, Malignant
  • Mesothelioma; Pleura
  • Mesotheliomas Pleural
  • Mesothelioma Peritoneum
  • Cholangiocarcinoma
  • Cholangiocarcinoma Recurrent
  • Ovarian Cancer
  • Non Small Cell Lung Cancer
  • Non Small Cell Lung Cancer Metastatic

Approved drugs for the same conditions: Small cell lung cancer · Ovarian cancer · Oncology · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "gavo-cel" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 1 on PubMed

Also in development for Mesothelioma

  • VT3989Phase 32 trials

    Vivace Therapeutics, Inc · Pleural Mesothelioma, Mesothelioma, Solid Tumor, Adult

  • ODM-212Phase 22 trials

    Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer

  • RSO-021ThiostreptonPhase 21 trial

    RS Oncology LLC · Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma

  • VMD-928Phase 21 trial

    VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.